Literature DB >> 31792043

Molecular regulation of Snai2 in development and disease.

Wenhui Zhou1,2, Kayla M Gross1,2, Charlotte Kuperwasser3,2.   

Abstract

The transcription factor Snai2, encoded by the SNAI2 gene, is an evolutionarily conserved C2H2 zinc finger protein that orchestrates biological processes critical to tissue development and tumorigenesis. Initially characterized as a prototypical epithelial-to-mesenchymal transition (EMT) transcription factor, Snai2 has been shown more recently to participate in a wider variety of biological processes, including tumor metastasis, stem and/or progenitor cell biology, cellular differentiation, vascular remodeling and DNA damage repair. The main role of Snai2 in controlling such processes involves facilitating the epigenetic regulation of transcriptional programs, and, as such, its dysregulation manifests in developmental defects, disruption of tissue homeostasis, and other disease conditions. Here, we discuss our current understanding of the molecular mechanisms regulating Snai2 expression, abundance and activity. In addition, we outline how these mechanisms contribute to disease phenotypes or how they may impact rational therapeutic targeting of Snai2 dysregulation in human disease.
© 2019. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Cancer; Development; Slug

Year:  2019        PMID: 31792043     DOI: 10.1242/jcs.235127

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  20 in total

Review 1.  MicroRNAs and Corresponding Targets in Esophageal Cancer as Shown In Vitro and In Vivo in Preclinical Models.

Authors:  Ulrich H Weidle; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2022 Mar-Apr       Impact factor: 4.069

2.  SNAI2-Mediated Repression of BIM Protects Rhabdomyosarcoma from Ionizing Radiation.

Authors:  Long Wang; Nicole R Hensch; Kathryn Bondra; Prethish Sreenivas; Xiang R Zhao; Jiangfei Chen; Rodrigo Moreno Campos; Kunal Baxi; Angelina V Vaseva; Benjamin D Sunkel; Berkley E Gryder; Silvia Pomella; Benjamin Z Stanton; Siyuan Zheng; Eleanor Y Chen; Rossella Rota; Javed Khan; Peter J Houghton; Myron S Ignatius
Journal:  Cancer Res       Date:  2021-08-30       Impact factor: 12.701

3.  Glucocorticoids activate Yes-associated protein in human vocal fold fibroblasts.

Authors:  Ryosuke Nakamura; Renjie Bing; Carina P Doyle; Michael J Garabedian; Ryan C Branski
Journal:  Exp Cell Res       Date:  2021-06-02       Impact factor: 4.145

4.  Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity.

Authors:  Ying Z Mazzu; YuRou Liao; Subhiksha Nandakumar; Martin Sjöström; Lina E Jehane; Romina Ghale; Barani Govindarajan; Travis A Gerke; Gwo-Shu Mary Lee; Jian-Hua Luo; Sreenivasa R Chinni; Lorelei A Mucci; Felix Y Feng; Philip W Kantoff
Journal:  Mol Oncol       Date:  2022-02-11       Impact factor: 7.449

5.  NF-κB-mediated lncRNA AC007271.3 promotes carcinogenesis of oral squamous cell carcinoma by regulating miR-125b-2-3p/Slug.

Authors:  Ze-Nan Zheng; Guang-Zhao Huang; Qing-Qing Wu; Heng-Yu Ye; Wei-Sen Zeng; Xiao-Zhi Lv
Journal:  Cell Death Dis       Date:  2020-12-12       Impact factor: 8.469

6.  RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.

Authors:  Dan Yu; Min Pan; Yanshi Li; Tao Lu; Zhihai Wang; Chuan Liu; Guohua Hu
Journal:  J Exp Clin Cancer Res       Date:  2022-01-03

7.  A 3D Renal Proximal Tubule on Chip Model Phenocopies Lowe Syndrome and Dent II Disease Tubulopathy.

Authors:  Sindhu Naik; Andrew R Wood; Maté Ongenaert; Paniz Saidiyan; Edo D Elstak; Henriëtte L Lanz; Jan Stallen; Richard Janssen; Elizabeth Smythe; Kai S Erdmann
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

8.  Loss of SNAI2 in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy.

Authors:  Marek Cmero; Natalie J Kurganovs; Ryan Stuchbery; Patrick McCoy; Corrina Grima; Anne Ngyuen; Ken Chow; Stefano Mangiola; Geoff Macintyre; Nicholas Howard; Michael Kerger; Philip Dundee; Paul Ruljancich; David Clarke; Jeremy Grummet; Justin S Peters; Anthony J Costello; Sam Norden; Andrew Ryan; Phillip Parente; Christopher M Hovens; Niall M Corcoran
Journal:  JCO Precis Oncol       Date:  2021-06-22

9.  Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer.

Authors:  Maria Victoria Recouvreux; Matthew R Moldenhauer; Koen M O Galenkamp; Michael Jung; Brian James; Yijuan Zhang; Andrew Lowy; Anindya Bagchi; Cosimo Commisso
Journal:  J Exp Med       Date:  2020-09-07       Impact factor: 14.307

10.  Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis.

Authors:  Jake J Reske; Mike R Wilson; Jeanne Holladay; Rebecca A Siwicki; Hilary Skalski; Shannon Harkins; Marie Adams; John I Risinger; Galen Hostetter; Ken Lin; Ronald L Chandler
Journal:  PLoS Genet       Date:  2021-12-23       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.